AKT1 and osteosarcoma: Previous studies have indicated that elevated levels of OIP5-AS1 induce resistance to oxaliplatin in CRC [28] and enhance resistance to cisplatin in osteosarcoma cells by activating the LPAATβ/PI3K/AKT/mTOR signaling axis [29].